Jul 24, 2015

FDA OKs breakthrough cholesterol drug for high-risk patients

WASHINGTON (AP) — The Food and Drug Administration on Friday approved a first-of-a-kind drug that lowers artery-clogging cholesterol more than older drugs that have been prescribed for decades. The drug from Sanofi and Regeneron Pharmaceuticals Inc. offers an important new option for millions of patients at high risk of heart disease. But the drug's sky-high price tag — $14,600 per year — is...

Proceed to the page: http://linkis.com/beX84

Similar Articles Added Earlier

Similar Articles Added Today

Latest Links Processed